GPCR NewsJul 31, 20221 min readGPCR PapersKaruna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...August 2022 Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia "BOSTON--(BUSINESS...